Search Within

Lara Dunn

Formats
  1. Meeting Abstract (81)
  2. Journal Article (50)
  3. Review (7)
  4. Book Section (1)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (141)
  2. Head and Neck Service (141)
  3. Solid Tumor Oncology Division (141)
  4. Weinberg Fellows (141)
  5. Radiation Oncology, Department of (72)
  6. Surgery (65)

More Groups

People
  1. Eric Sherman (77)
  2. David Pfister (60)
  3. Nancy Lee (60)
  4. Sean McBride (57)
  5. Alan Ho (54)
  6. Nadeem Riaz (52)

More People

Years
  1. 2025 (3)
  2. 2024 (22)
  3. 2023 (10)
  4. 2022 (11)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. International Journal of Radiation Oncology, Biology, Physics (24)
  3. Annals of Oncology (9)
  4. Journal for ImmunoTherapy of Cancer (8)
  5. Head & Neck (6)
  6. Oral Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (43)
  2. Elsevier Inc. (30)
  3. Oxford University Press (10)
  4. Biomed Central Ltd (8)
  5. John Wiley & Sons, Inc. (6)
  6. Wiley Blackwell (6)

More Publishers

Results (141)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Ho, A. L.; Ganly, I.; Riaz, N.; Morris, L.; Hung, K. W.; Kriplani, A.; Cracchiolo, J. R.; Cohen, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation and expansion study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, given alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+head and neck cancer
    Meeting Abstract

    Chung, C. H.; Colevas, A. D.; Adkins, D.; Gibson, M. K.; Rodriguez, C. P.; Sukari, A.; Bauman, J. E.; Wirth, L. J.; Johnson, F. M.; Saba, N. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Primary analysis of phase 2 results for cemiplimab in patients with mBCC who progressed on or were intolerant to hedgehog inhibitors
    Meeting Abstract

    Lewis, K. D.; Peris, K.; Sekulic, A.; Stratigos, A. J.; Dunn, L.; Eroglu, Z.; Chang, A. L. S.; Migden, M. R.; Yoo, S. K.; Mohan, K.; more...
    Journal of Oncology Navigation & Survivorship (2022)

    Fulltext@MSK | Save
  • Physician graded toxicity profiles and survival outcomes among patients with non-metastatic oropharyngeal carcinoma treated with proton therapy vs. intensity-modulated radiation therapy
    Meeting Abstract

    Youssef, I.; Yoon, J. J.; Zakeri, K.; Cohen, M.; Wong, R. J.; Yu, Y.; Kang, J. J.; Gelblum, D.; McBride, S. M.; Sherman, E.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirusā€“associated oropharyngeal carcinoma treated with definitive chemoradiotherapy
    Journal Article

    Tsai, C. J.; McBride, S. M.; Riaz, N.; Kang, J. J.; Spielsinger, D. J.; Waldenberg, T.; Gelblum, D.; Yu, Y.; Chen, L. C.; Zakeri, K.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • NKTR-255+cetuximab in patients with solid tumors: Interim safety and efficacy results from the phase 1b dose-escalation study
    Meeting Abstract

    Altan, M.; Patnaik, A.; Barve, M.; Dunn, L.; Cobb, P.; Rosenberg, A.; Sharma, S.; Sukari, A.; Patel, M.; Wang, X.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • A phase 1 trial of cue-101, a novel Hpv16 E7-Phla-Il2-Fc fusion protein, alone and in combination with pembrolizumab in patients with recurrent/metastatic Hpv16+ head and neck cancer
    Meeting Abstract

    Chung, C.; Colevas, A. D.; Gibson, M.; Adkins, D.; Sukari, A.; Wirth, L.; Burtness, B.; Bauman, J.; Rodriguez, C.; Worden, F.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Enhanced pathologic tumor response with two cycles of neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV-negative head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Uppaluri, R.; Chernock, R.; Mansour, M.; Jackson, R.; Rich, J.; Pipkorn, P.; Paniello, R. C.; Puram, S.; Zevallos, J. P.; Annino, D. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Postoperative PET/CT for detection of early recurrence (ER) after surgery for squamous cell carcinomas (SCC) of the oral cavity (OC)
    Meeting Abstract

    Yu, Y.; SchoĢˆder, H.; Kang, J.; McBride, S. M.; Tsai, C. J.; Chen, L.; Zakeri, K.; Gelblum, D. Y.; Boyle, J.; Cracchiolo, J. R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save